This study investigates advanced solid tumors. It evaluates the safety and tolerability of an investigational medication called oncolytic vaccinia virus GC001.
The focus of the study is to assess the safety and how the investigational medication behaves in the body. Researchers are looking at how the virus spreads and the body's immune response to it.
- Who can participate: Adults aged 18 to 75 years with advanced solid tumors and measurable lesions suitable for intratumoral injection may participate.
- Study details: Participants will receive an injection of the investigational medication. Some may receive a placebo, an inactive substance that looks like the investigational medication but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand